Bilaketaren emaitzak - Brain, Etienne

Long term response to erlotinib in a patient with recurrent vulvar carcinoma: Case report and review of literature() nork Inrhaoun, Hanane, Elghissassi, Ibrahim, Gutierrez, Maya, Brain, Etienne, Errihani, Hassan

Testu osoa Testu osoa Testu osoa

Population pharmacokinetics and exploratory pharmacodynamics of ifosfamide according to continuous or short infusion schedules: an n = 1 randomized study nork Brain, Etienne G C, Rezai, Kevan, Lokiec, François, Gutierrez, Maya, Urien, Saïk

Testu osoa Testu osoa Testu osoa

Chemoradiation in elderly esophageal cancer patients: rationale and design of a phase I/II multicenter study (OSAGE) nork Servagi-Vernat, Stéphanie, Créhange, Gilles, Bonnetain, Franck, Mertens, Cécile, Brain, Etienne, Bosset, Jean François

Testu osoa Testu osoa Testu osoa

New Frontiers for Fairer Breast Cancer Care in a Globalized World nork Verhoeven, Didier, Allemani, Claudia, Kaufman, Cary, Siesling, Sabine, Joore, Manuela, Brain, Etienne, Costa, Mauricio Magalhães

Testu osoa Testu osoa Testu osoa

Are Older Patients with Cervical Cancer Managed Differently to Younger Patients? An International Survey nork Frelaut, Maxime, De Glas, Nienke, Zapardiel, Ignacio, Kaidar-Person, Orit, Kfoury, Maria, You, Benoit, Banerjee, Susana, Brain, Etienne, Falandry, Claire, Rodrigues, Manuel

Testu osoa Testu osoa Testu osoa

Taking care of older patients with cancer in the context of COVID-19 pandemic nork Mourey, Loïc, Falandry, Claire, de Decker, Laure, Boulahssass, Rabia, Carola, Elisabeth, Bengrine Lefevre, Leila, Cudennec, Tristan, Brain, Etienne, Paillaud, Eléna, Soubeyran, Pierre

Testu osoa Testu osoa Testu osoa

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity nork Brignone, Chrystelle, Gutierrez, Maya, Mefti, Fawzia, Brain, Etienne, Jarcau, Rosana, Cvitkovic, Frédérique, Bousetta, Nabil, Medioni, Jacques, Gligorov, Joseph, Grygar, Caroline, Marcu, Manon, Triebel, Frédéric

Testu osoa Testu osoa Testu osoa

Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study nork Bidard, François-Clément, Hajage, David, Bachelot, Thomas, Delaloge, Suzette, Brain, Etienne, Campone, Mario, Cottu, Paul, Beuzeboc, Philippe, Rolland, Emilie, Mathiot, Claire, Pierga, Jean-Yves

Testu osoa Testu osoa Testu osoa

Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival nork Rochefort, Pauline, Chabaud, Sylvie, Pierga, Jean-Yves, Tredan, Olivier, Brain, Etienne, Bidard, François-Clément, Schiffler, Camille, Polena, Helena, Khalil-Mgharbel, Abir, Vilgrain, Isabelle, Bachelot, Thomas

Testu osoa Testu osoa Testu osoa

Long term outcome data from the EORTC 75111-10114 ETF/BCG randomized phase II study: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2... nork Wildiers, Hans, Meyskens, Thomas, Marréaud, Sandrine, Lago, Lissandra Dal, Vuylsteke, Peter, Curigliano, Giuseppe, Waters, Simon, Brouwers, Barbara, Meulemans, Bart, Sousa, Berta, Poncet, Coralie, Brain, Etienne

Testu osoa Testu osoa Testu osoa

A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer nork Janni, Wolfgang, Sarosiek, Tomasz, Karaszewska, Boguslawa, Pikiel, Joanna, Staroslawska, Elzbieta, Potemski, Piotr, Salat, Christoph, Brain, Etienne, Caglevic, Christian, Briggs, Kathryn, DeSilvio, Michelle, Marini, Luca, Papadimitriou, Christos

Testu osoa Testu osoa Testu osoa

Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated... nork Sabatier, Renaud, Diéras, Véronique, Pivot, Xavier, Brain, Etienne, Roché, Henri, Extra, Jean-Marc, Monneur, Audrey, Provansal, Magali, Tarpin, Carole, Bertucci, François, Viens, Patrice, Zemmour, Christophe, Gonçalves, Anthony

Testu osoa Testu osoa Testu osoa

Perspectives on cancer care in older patients in France nork Hauchecorne, Mathilde, Pierro, Monica, Brain, Etienne, Bringuier, Michael, Soubeyran, Pierre, Chakiba, Camille, Mathoulin-Pelissier, Simone, Paillaud, Elena, Geiss, Romain, Besse, Benjamin, Mourey, Loïc, Vincent, Hélène, Baldini, Capucine

Testu osoa Testu osoa Testu osoa

Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial nork Cabel, Luc, Berger, Frédérique, Cottu, Paul, Loirat, Delphine, Rampanou, Aurore, Brain, Etienne, Cyrille, Stacy, Bourgeois, Hugues, Kiavue, Nicolas, Deluche, Elise, Ladoire, Sylvain, Campone, Mario, Pierga, Jean-Yves, Bidard, Francois-Clement

Testu osoa Testu osoa Testu osoa

Plasma thymidine kinase 1 activity and outcome of ER+ HER2− metastatic breast cancer patients treated with palbociclib and endocrine therapy nork Cabel, Luc, Rosenblum, Dan, Lerebours, Florence, Brain, Etienne, Loirat, Delphine, Bergqvist, Mattias, Cottu, Paul, Donnadieu, Anne, Bethune, Anne, Kiavue, Nicolas, Rodrigues, Manuel, Pierga, Jean-Yves, Tanguy, Marie-Laure, Bidard, François-Clément

Testu osoa Testu osoa Testu osoa

Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial nork Hamy, Anne-Sophie, Tury, Sandrine, Wang, Xiaofei, Gao, Junheng, Pierga, Jean-Yves, Giacchetti, Sylvie, Brain, Etienne, Pistilli, Barbara, Marty, Michel, Espié, Marc, Benchimol, Gabriel, Laas, Enora, Laé, Marick, Asselain, Bernard, Aouchiche, Brice, Edelman, Martin, Reyal, Fabien

Testu osoa Testu osoa Testu osoa

Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial nork López-Miranda, Elena, Pérez-García, José Manuel, Di Cosimo, Serena, Brain, Etienne, Ravnik, Maja, Escrivá-de-Romaní, Santiago, Vidal, Maria, Gligorov, Joseph, Borštnar, Simona, Calabuig, Laura, Sampayo-Cordero, Miguel, Malfettone, Andrea, Llombart-Cussac, Antonio, Suter, Thomas M., Cortés, Javier

Testu osoa Testu osoa Testu osoa

International Society of Geriatric Oncology Consensus on Geriatric Assessment in Older Patients With Cancer nork Wildiers, Hans, Heeren, Pieter, Puts, Martine, Topinkova, Eva, Janssen-Heijnen, Maryska L.G., Extermann, Martine, Falandry, Claire, Artz, Andrew, Brain, Etienne, Colloca, Giuseppe, Flamaing, Johan, Karnakis, Theodora, Kenis, Cindy, Audisio, Riccardo A., Mohile, Supriya, Repetto, Lazzaro, Van Leeuwen, Barbara, Milisen, Koen, Hurria, Arti

Testu osoa Testu osoa Testu osoa

Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial nork Jacot, William, Cottu, Paul, Berger, Frederique, Dubot, Coraline, Venat-Bouvet, Laurence, Lortholary, Alain, Bourgeois, Hugues, Bollet, Marc, Servent, Veronique, Luporsi, Elisabeth, Espié, Marc, Guiu, Severine, D’Hondt, Veronique, Dieras, Veronique, Sablin, Marie-Paule, Brain, Etienne, Neffati, Souhir, Pierga, Jean-Yves, Bidard, Francois-Clement

Testu osoa Testu osoa Testu osoa

Phase III trial (EORTC 10994/BIG 1-00) assessing the value of p53 using a functional assay to predict sensitivity to a taxane versus non taxane primary chemotherapy in breast cance... nork Bonnefoi, Hervé, Piccart, Martine, Bogaerts, Jan, Mauriac, Louis, Fumoleau, Pierre, Brain, Etienne, Petit, Thierry, Rouanet, Philippe, Jassem, Jacek, Blot, Emmanuel, Zaman, Khalil, Cufer, Tanja, Lortholary, Alain, Lidbrink, Elisabet, André, Sylvie, Litière, Saskia, Lago, Lissandra Dal, Becette, Véronique, Cameron, David A., Bergh, Jonas, Iggo, Richard

Testu osoa Testu osoa Testu osoa